Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

DOCEHOPE Concentrate for Solution for Infusion 80 mg/ 4 ml

Approval Number

SIN16942P

Drug Name

DOCEHOPE Concentrate for Solution for Infusion 80 mg/ 4 ml

Product Name

DOCEHOPE Concentrate for Solution for Infusion 80 mg/ 4 ml

Approval Date

February 7, 2024

Registrant

GLENMARK PHARMACEUTICALS SINGAPORE PTE. LTD.

Regulatory Information

Registrant

GLENMARK PHARMACEUTICALS SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INFUSION, SOLUTION CONCENTRATE

Route of Administration

INTRAVENOUS

Medical Information

ATC Code

L01CD02

ATC Item Name

docetaxel

Manufacturer Information

Pharmaceutical Manufacturer

GLENMARK PHARMACEUTICALS SINGAPORE PTE. LTD.

Manufacturers

Glenmark Generics S.A.

Active Ingredients

Ingredient Name

Docetaxel Anhydrous

Strength

80 mg / 4 ml

Drug MonographDocetaxel

Documents

Package Inserts

Docehope Concentrate for Solution for Infusion PI.pdf

Approved: February 7, 2024

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

DOCEHOPE Concentrate for Solution for Infusion 80 mg/ 4 ml - HSA Approval | MedPath